Rhesus-associated glycoprotein is a critical co-factor in the expression of rhesus blood group antigens. We identified and cloned an erythroid-specific major DNase I-hypersensitive site located about 10 kilobases upstream from the translation start site of the RHAG gene. A short core enhancer sequence of 195 base pairs that corresponded with the major hypersensitive site and possessed position-and orientation-independent enhancer activity in K562 cells. In vitro DNase I footprint analysis revealed four protected regions in the core enhancer; two GATA motifs, an Ets-like motif and an unknown motif. The GATA motifs bound GATA-1 and mutagenesis analysis revealed that the proximal one is critical for the enhancing activity. Homology plot analysis using the 5 sequence of the mouse RHAG gene revealed four homologous stretches and multiple insertions of repetitive sequences among them; four LINE/L1 and four Alu in the human and as well as one LINE/L1 and one LTR/MaLR in the mouse gene. The highly conservative enhancer region was flanked by SINE and LINE/L1 in both species. These results suggest that the 5-flanking sequence of RHAG gene is a preferable target sequence for retroviral transposition and that the enhancer was inserted in the same manner, resulting in the acquisition of erythroid dominant expression.
The rhesus (Rh) 1 blood group antigens are a considerably important blood group system in transfusion medicine and newborn or autoimmune hemolytic diseases for their high antigenicity (1) . The Rh antigens are carried by two distinct but homologous integral membrane proteins of 30 -32 kDa that were isolated by immunoprecipitation studies using anti-Rh antibodies (2) . Two cDNAs corresponding to them have been cloned, RHCE (3, 4) and RHD (5-7) cDNAs, which differed by only 31-35 amino acids within a total of 417 residues and were mapped in tandem on chromosome 1q34.3-36.1. In addition to the 30 -32-kDa Rh polypeptides, the anti-Rh antibodies simultaneously precipitated a glycoprotein with a apparent molecular mass of 45-100 kDa (the Rh-associated glycoprotein (RhAG)) (8, 9) . Moreover, Hartel-Schenk and Agre (10) coprecipitated Rh macrocomplex as a 170-kDa complex by density ultracentrifugation of [H 3 ]palmitate-labeled Rh30 proteins, suggesting that RhD or CE polypeptide and Rh50 glycoprotein may be closely associated in the erythrocyte membrane. The cDNA of RhAG has been cloned by Ridgwell et al. (11) . The predicted amino acid sequence showed similarity with Rh proteins in both amino acid sequence and predicted membrane topology.
The Rh deficiency syndrome (Rh null phenotype) is characterized by the morphological and functional abnormalities of red blood cells associated with the lack of expression of Rh antigens (12) . Two genetic backgrounds have been proposed to the Rh null phenotype (13) , the most common type by Rh null regulator gene and second type by amorph gene that arose by homozygosity of a silent allele at the RH locus. Recently, it has been proposed that the RHAG gene acts as the regulator gene, mainly because the mutant alleles of RHAG gene were found in Rh null cases (14 -16) . Therefore, the RhAG is regarded as a critical co-expressing factor on red blood cells. In contrast to the pathological role, the physiological function is still not fully understood. Although the presence of RHAG-like gene has been shown in Caenorhabditis elegans and Geodia cydonium (14, 17) , which do not have circulating blood cells, the expression of RhAG in Homo sapiens (18) and the orthologue in Mus musculus (19) dominate in erythroid cells.
The distribution of RH transcripts has been also shown to exist in the cells with erythroid features in hematopoietic cell lineage (3) . The promoter sequences of RH genes support the erythroid-specific expression of the Rh antigens (20) . To know the expression regulatory mechanisms of RHAG gene, we have identified the 1.8-kb promoter region in the previous study (18) . A short core promoter was identified that included an inverse GATA motif and acted as a weak erythroid dominant promoter. However, 1.8 kb further upstream sequence behaved as suppressive elements and almost diminished the transactivating function of the core promoter. These results indicated further distant cis-acting regulatory elements in this gene. The human ␤-globin locus is controlled by the locus control region (LCR), which was localized at positions between Ϫ21.5 and Ϫ6.1 kb from the ⑀ globin cap site (21, 22) . The LCR is able to open the ␤-globin locus, enhance transcription, and control the timing and origin of DNA replication of the locus (22 sites (HSs). In this study, we have identified a major HS in RHAG gene and characterized the enhancing activity. If the regulatory mechanisms of expressing the Rh antigens are fully understood, it will contribute a clinical regulation for suppressing the expression to avoid the harmful hemolytic reactions in newborn or auto-immune hemolytic diseases.
MATERIALS AND METHODS
DNase I Hypersensitivity Analysis-The erythroleukemic cell lines K562 and HEL and the epithelial cell line HeLa were obtained from Health Science Research Resources Bank (Osaka, Japan) and maintained in RPMI 1640 (K562 and HEL) or Dulbecco's modified Eagle's medium (HeLa) containing 10% fetal calf serum. Nuclei from the three cell lines were isolated as described elsewhere (23) by disruption of plasma membrane with 0.25% Triton X-100 (Sigma) in ice-cold phosphate-buffered saline followed by centrifugation at 2000 ϫ g through a 0.88 M sucrose solution in isotonic buffer (25 mM KCl, 1 mM EDTA, 1 mM EGTA, 0.55 mM spermine, 1.5 mM spermidine, 50 mM Tris-HCl, pH 7.0). Nuclei were resuspended at a concentration of 2 ϫ 10 7 /ml in DNase I digestion buffer (60 mM KCl, 15 mM NaCl, 15 mM Tris-HCl, pH 7.4, 0.5 mM dithiothreitol, 0.25 mM sucrose, 3 mM MgCl 2 , and 0.05 mM CaCl 2 ). Aliquots (0.25 ml) were digested with increasing concentration of DNase I (0 -15 g/ml) (Takara, Kyoto, Japan) at 37°C for 7 min. Nuclease reactions were stopped by addition of 12.5 l of 10% SDS and 5 l of 0.5 M EDTA. Genomic DNA was purified by digestion with proteinase K followed by extraction with phenol/chloroform. 10 g of purified DNA each were digested with sufficient units of restriction endonucleases, EcoRI, XhoI, or SacI. Digested DNA was electrophoresed on 0.8% agarose gel and transferred onto Hybond-Nϩ nylon membrane (Amersham Pharmacia Biotech). The blot membranes were initially hybridized with human RHAG 5Ј probe, probe A in Fig. 1 encoding from nt Ϫ1868 to Ϫ1122, for 24 h at 65°C and washed in 0.1 ϫ SSPE with 0.1% SDS for 30 min at 65°C. After autoradiography, the membranes were stripped and rehybridized successively with probes B, C, D, and E illustrated in Fig. 1B .
Cloning of DNase I-hypersensitive Sequence of Human and Murine RHAG Genes-Results of DNase I hypersensitivity analysis indicated that the erythroid-specific major HS in human is encoded in the 15-kb SacI fragment. Genomic DNA from an Rh-positive healthy volunteer was digested with SacI, and DNA fragments were sized by low temperature melting gel. DNA fraction with almost 15 kb length were rescued and ligated in DASH vector (Stratagene, La Jolla, CA). The phage library (1.6 ϫ 10 5 clone) was screened by probe A, and a positive clone was subcloned into pUC18 vector and sequenced.
The 5Ј-flanking sequence of murine RHAG gene was cloned through PCR screening of BAC library from mouse strain 129Svj (Genome Systems Inc., St. Louis, MO). A sense (TACCACATTCTACATTGT, corresponding to nt 781-807) and an antisense (ATCATAGCAACTTC-CAGGCTTATGGCC, complementary to nt 1044 -1070) primers were designed according to the previous data (19) and used for PCR screening. A positive BAC clone was mapped by Southern blotting study with the mouse PCR probe and human probe encoding the major HS. A SacI fragment hybridized with both probes was subcloned into pUC vector and sequenced. Analysis of the nucleotide sequences was performed with DNASIS-Mac (Hitachi software engineering Co., Ltd., Hitachi, Japan) and GENETYX-Mac (Software Development Co., Ltd., Tokyo, Japan). Estimation of binding motifs of the transcription factors and the repetitive sequences was performed by website software: TFSEARCH and RepeatMasker2 web server, respectively.
Plasmid Constructs and Mutant Derivatives-The 5Ј-flanking DNA of human RHAG gene was PCR amplified with sense (TTTGGAAAT-GCTAGTGCTG, corresponding to nt Ϫ3924 to Ϫ3906) and antisense (TGAACCCCATGGTTGTGGCAAAGGACAG, complimentary to nt Ϫ20 to ϩ3) primers to correct the transcription initiation codon into NcoI restriction site. The PCR fragment was digested with NcoI and ligated with the firefly luciferase cassette from pGL3-basic (Promega, Madison, WI) to create pGL-Nc. The sequence was verified by sequence analysis to exclude the possibility of misincorporation through PCR reaction. The DNA fragment from KpnI to AatI was excised from pGL-Nc and replaced with that of DASHrhag-5.2 to create pGL-Kp, which encoded from nt Ϫ11191 to ϩ3. According to the mapping data of HS, serial deletion mutants from upstream and downstream were constructed using the pGL-Kp and unique restriction sites. Each deletion construct was nomenclatured by the used restriction enzymes, i.e. pGLKp⌬KpSn⌬SpPf indicates deletions of two fragments from KpnI to SnaBI and from SpeI to PflMI. To convert the orientation of DNase I hypersensitive element, the 5.6-kb HindIII fragment was excised from pGL-Kp and religated anti-directionally. The construct was arranged further by deletions of two fragments from KpnI to SpeI and from BlpI to PflMI (pGL-Kp⌬KpBl⌬SpPf-inv). The DNA fragment from BlpI to SpeI was ligated in also downstream of luciferase gene of pGL-Kp⌬KpPf (pGL-Kp⌬KpPf-dn).
Site-directed mutagenesis of the predicted motifs in the minimum enhancer was carried out using a PCR-based method of Imai et al. (24) with some modifications. The pGL-Kp⌬KpBl⌬ApPf was amplified with following primers and high fidelity DNA polymerase, Pfu Turbo (Stratagene). PCR fragments were treated with T4 DNA polymerase (Takara) and ligated into monomeric form with T4 DNA ligase (Life Technologies Inc.). The PCR derived mutant clones were verified by sequence reaction. The enhancer and promoter sequences with intended mutations were re-excised from the vector and recloned into NotI/NarI site of pGL3 basic vector. Mut1a (CATGCCACTGCTTGCTGAG) and M1 s (CTGATAAACTATAGTGGGGA) were used to disrupt NF-E1 motif. M2a (CATGCCTCAGCTTGCTGAG) and Mut2s (CTGCTAAACTATA-GTGGGGA) were used to disrupt distal GATA1. M3a (GAATTGAAG-AGCTTCCCAGA) and Mut3s (CAACCTTAGCTTTGAAAAGC) were used to disrupt proximal GATA1. M3a and P-GA1s (TCCAACCTTAT-CTTTGAAAAG) were used to disrupt Ets core motif. D-GA1a (ACTA-TAGTTTATCAGCATGC) and P-GA1s were used to introduce a deletion from nt Ϫ9723 to Ϫ9651. P-GA1a (GCTGCTTTTCAAAGATAAGGTT-GG) and Ϫ160 s (GTGGGGCATTTTAATCAGTC) were used to introduce a deletion from Ϫ9625 to 3Ј end of the enhancer fragment.
Transduction and Reporter Enzyme Assay-For transfection, 5 ϫ 10 5 K562 cells were co-transfected with 0.4 g of the pGL3-RHAG enhancer/promoter (firefly luciferase) plasmid and 0.08 g of the pRL-CMV (renilla luciferase, Promega) by lipofection procedure using LipofectAMINE (Life Technologies, Inc.). 24 h after transfection, cells were harvested and lysed in lysis buffer (Promega). The relative light units (firefly/renilla light units) were measured by dual luciferase reporter assay system (Promega) in a TD-20/20 luminometer (Turner Designs, Sunnyvale, CA). For all transfection assays, at least three independent experiments were performed. DNase I Footprinting-Nuclear extracts from K562 and HeLa cells were prepared by the mini-extract method of Schreiber et al. (25) . In brief, 1 ϫ 10 6 cells were harvested in a 1.5-ml tube and washed in phosphate-buffered saline. The washed cells were resuspended in buffer A (10 mM HEPES-KOH, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 0.5% Nonidet-P40). Nuclei were pelleted and resuspended in ice-cold high salt buffer C (20 mM HEPES-KOH, pH 7.9, 0.3 M KCl, 1.5 mM MgCl 2 , 0.1 mM EDTA, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride). After 20 min of incubation, chromatin was pelleted, and nuclear extract was collected in a fresh tube. Protein concentration was measured by Bradford assay.
Nonradioactive DNase I footprinting reactions were performed according to the conventional radioactive method. The DNA fragment from nt Ϫ9756 to Ϫ9315 was subcloned into pCR2.1 vector (Invirtogen). Double-stranded DNA probes were 5Ј end-labeled by PCR with fluorescein isothiocyanate-conjugated universal (T7 and RV) primers. The probes were isolated by low temperature melting gel. In a total of 60 l of reaction mix, 75 ng (200 fmol) of the double-stranded probes were incubated with or without 18 g of nuclear extracts and with 6 g of poly(dI-dC) (Amersham Pharmacia Biotech) in 1ϫ binding buffer (10 mM HEPES-KOH, pH 7.9, 50 mM KCl, 1 mM EDTA, 5 mM MgCl 2 , 10% glycerol, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride). Following 30 min of incubation in room temperature, 0.05 units of DNase I (Takara) were added into the reaction mixture at 20°C. After 30 s of digestion, the reaction was quenched by SDS and EDTA. The DNA fragments were analyzed on 5% acrylamide gel to be analyzed by electrophoresis on DSQ2000 DNA sequencer (Shimazu, Kyoto, Japan). As a size marker lane, the products of sequence reaction with each labeled primers were electrophoresed on the same gel.
Electrophoretic Mobility Shift Assay (EMSA)-EMSA reactions were performed with nuclear extract of K562. Briefly, 5 pmol of annealed oligonucleotide probes were labeled with Klenow fragment (Takara) and [ 32 P]dCTP, and purified by nucleotide removal kit (Qiagen, Tokyo, Japan). Each 10-l reaction contained 50 fmol of labeled probe, 1 g of poly(dI-dC), and 6 g of nuclear extract protein in 1ϫ binding buffer. In competition experiments, 2.5 pmol of unlabeled double-stranded oligonucleotides were added to the reaction mixtures. For supershift assays, 1 l of rat monoclonal anti-GATA1 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was added. Samples were incubated for 30 min at room temperature and analyzed on 5% acrylamide gel in 0.5ϫ TBE buffer at room temperature. After electrophoresis the gel was dried and exposed to an x-ray film. The oligonucleotides used in EMSA were as follows: probe 1 (GGCTCAGCAAGCTGAGGCATG and M2a), 1M (GG-CTCAGCAAGCAGTGGCATG and Mut1a), probe 2 (GAGGCATGCTG-ATAAACTATAG and D-GA1a), 2M (GAGGCATGCTGCTAAACTATAG and ACTATAGTTTAGCAGCATGCCT), probe3 (GAAATAAAGATCTG-TCATATTTT-3Ј and GAAAATATGACAGATCTTTATTT), probe 4 (TT-TCTGGGAAGCTCTTCAAT and M3a), probe 5 (GAAGCTCTTCAATT-CCAACCTTAT and GATAAGGTTGGAATTGAAGAGCTT), probe 6 (PGA1s and P-GA1a), and 6M (Mut3s and GCTGCTTTTCAAAGCTAAG-GTTGG).
RESULTS

Mapping of DNase I Hypersensitivity of RH50 Gene-To
identify the regulatory region of the RHAG gene, DNase I hypersensitivity analysis was employed. Probe A initially detected intense 10-kb and weak 2.8-kb hypersensitive bands in the XhoI-digested genome of K562 and HEL but not in that of HeLa cells (Fig. 1A) . Probes B and C detected weak bands in the XhoI-and EcoRI-digested genome of K562, and probe D detected a weak band in XhoI-digested genome. DNase I-sensitive10-kb bands and weak 2.8-kb bands reappeared in the SacI-digested genome of K562 and HEL but not in that of HeLa cells. The 10-kb hypersensitive bands appeared in also another erythroleukemic cell line expressing RHAG, KU812E, but not in nonexpressing myeloid cell line, HL60, and embryonic kidney cell line, HEK293 (not shown). These results suggest that the major erythroid-specific locus controlling region of the RHAG gene is located about 10 kb upstream from the first exon, which is included in the 15-kb SacI fragment, and that minor controlling regions are disseminated in intron 1 and downstream of the RHAG gene (Fig. 1B) .
Cloning of the Upstream Sequence of RH50 Gene-The 15-kb
SacI fragment was cloned from a healthy donor (Fig. 1A, lane  N) . Four positive clones, DASHrhag-5.1, -5.2, -10.1, and -10.2, were isolated through plaque hybridization screening of a genome library. Because all clones had identical restriction maps, the insert of a representative, DASHrhag-5.2, was subcloned into a plasmid and sequenced (GenBank TM accession number AB036993). RepeatMasker2 website analysis revealed multiple simple repeat units in the DNA sequence: four Alu, four SINE/ MIR, four LINE/L1, and two LINE/L2 repeats. The residual sequences did not show considerable similarity with data bases in GenBank TM . The 14874-bp 5Ј-flanking sequence from the translation initiating codon was AT-rich (A/T; 63.9%) except for the Alu repeats. Fig. 2B shows the diagram of the SacI fragment. For further fine mapping of the major HS, the filter blotted with the EcoRI-or XhoI-digested K562 genome was reprobed with probe E. Intense 1.85-kb bands and weak 1.45-, 1.2-, and 0.8-kb bands appeared in EcoRI fragments, whereas the genome digested with XhoI contained a weak 4-kb band ( Fig. 2A) . These results localized the major HS in the 2997-bp EcoRI fragment, confirming the findings of the initial DNase I hypersensitivity analysis.
Luciferase Analysis with 5Ј-Flanking Sequence of RH50 Gene-To functionally evaluate the major HS involved in transactivation, the DNA fragment from KpnI (nt Ϫ11195) to the translation initiating site (ϩ3) was subcloned into the pGL3 vector, and deletion derivatives were constructed. Reporter plasmids were introduced into K562 with pRL-SV40, and the transactivating functions were assayed as relative light units. Although short promoter fragment (pGL-Kp⌬KpPf) had weak transactivation activity, that of the full-length construct, pGL-Kp, was 7.4-fold that of pGL-Kp⌬KpPf (Fig. 3A) .
The activity of the construct, pGL-Nc, was almost equivalent to that of pGL-Kp⌬KpPf, despite the inclusion of a weak HS. When DNA fragments, from SpeI to AvrII or from SpeI to PflMI, were removed from pGL-Kp, the transactivation activity increased to 18.8-and 19.7-fold that of pGL-Kp⌬KpPf, respectively. These results localized the enhancing activity in upstream from the SpeI site, which is consistent with the findings of the DNase I hypersensitivity analysis.
For further fine localization, upstream or downstream deletions were introduced into construct pGL-Kp⌬SpPf using unique restriction sites (Fig. 3B ). Luciferase analysis with the deletion mutants indicated that the short (195bp) DNA fragment from BlpI to ApaI had sufficient enhancing activity, which was consistent with the major HS that appeared in the 2997-bp EcoRI fragment. To verify the short DNA fragment as an enhancer, the BlpI/SpeI fragment was inserted in the upside down orientation of pGL-Kp⌬KpBl⌬SpPf or downstream of the luciferase gene in short promoter construct, pGL-Kp⌬KpPf. The constructs, pGL-Kp⌬KpBl⌬SpPf-inv and pGL-Kp⌬KpPf-dn, had high (3.5-fold) and identical (1.0-fold) enhancing activity to that of the original direction construct, respectively (Fig.  3C) . These results indicate that the DNA fragment from nt Ϫ9756 to Ϫ9560 possesses position-and orientation-independent enhancer activity.
In Vitro DNase I Footprinting-To characterize the binding sites for cis-acting factors in the minimal enhancer, we used in vitro DNase I footprint analysis. Double-stranded probes labeled with fluorescein isothiocyanate were incubated with K562 or HeLa cell nuclear extracts before DNase I digestion and run in parallel to lanes containing probes incubated without extracts (Fig. 4) . The DNase I digestion ladders of the 
FIG. 3. Identification of an enhancer by functional assay of the 5-flanking region of human RHAG gene.
A, the top diagram shows the restriction enzyme and HS map. The solid vertical box is exon1. The full-length construct, pGL-Kp, is the parental vector to induce the deletion derivatives. The constructs were transfected into K562 cells, and the relative light units were measured. B, the pGL-Kp⌬SpPf construct was induced further deletion with restriction enzymes illustrated in the top diagram. The relative light units are shown as percentages of the parental vector, pGLKp⌬SpPf. C, the DNA fragment from the BlpI to the SpeI site was inserted in the upstream of the short promoter in the upside-down orientation, pGLKp⌬KpBl⌬SpPf-inv, or downstream of luciferase gene following the short promoter, pGL-Kp⌬KpPf-dn. directional and anti-directional probe fragments were protected on both strands by K562 extract clearly at a footprint indicated by vertical bars with number 4 and weakly at 3 footprints with numbers 1-3, whereas the ladder incubated with HeLa extracts was almost identical with that digested without nuclear proteins. The protected sequences in K562 extracts were identified by the adjacent sequence ladder primed with the same oligonucleotide used for probe labeling. Although two footprints were centered by a GATA motif and one was centered by an Ets core, the other did not match any known motif sequence. However, two other predicted motifs for hematopoietic cell related transcription factors, NF-E2 and STAT-X, were not protected (marked by arrows in Fig. 4 ). 50-bp (positive strand) and 130-bp (negative strand) downstream regions from the proximal GATA were hypersensitive to DNase I even without nuclear extract (white boxes). Adding nuclear protein of both K562 and HeLa enhanced the DNA hydrolysis.
Phylogenetic Analysis of the DNase I-hypersensitive SitesFor further analysis to predict cis-acting elements, we isolated a BAC clone (46N22) encoding murine RHAG gene from the 129Svj strain by PCR screening. The 46N22 clone encoded an insert of over 150 kb and hybridized not only with the PCR fragment encompassing a 290-bp 5Ј-flanking sequence of murine RHAG gene but also the human probe encoding the core enhancer fragment (not shown). A 5.8-kb SacI fragment that hybridized with both probes was subcloned into a plasmid vector and sequenced (GenBank TM accession number AB036994). The sequence of the 3Ј end (991 bp) of the SacI fragment was almost identical (8 bp diversity) to that of the BALB/c mouse deposited in GenBank TM (accession number AF057527) (19) . The SacI fragment encoded two LINE/L1, two SINE/Alu, and one LTR/MaLR simple repeat sequences.
The 14874-bp human and the 5811-bp murine RH50 5Ј-flanking sequences were compared by homology plot method using a window with 14 of 21 matches (Fig. 5A) . The computer analysis visualized four matching regions between human and mouse. A gap of over 5 kb was observed in the human sequence between the first and second linearly plotted area, which encoded three LINE/L1 and four Alu repeats. The most upstream aligned region, which corresponded with the major HS of human, was compared by maximum matching program. Fig. 5B shows the alignment of the upstream matched area for human nt Ϫ10074 to Ϫ9201 and murine nt Ϫ4701 to Ϫ3921. The 195-bp minimal enhancer from BlpI to ApaI showed the highest homology with the mouse sequence (74%), whereas the second, third, and fourth linearly plotted areas showed 60, 64, and 68% homology, respectively. In the minimal enhancer, a 23-bp phylogenetic footprint, which contained the GATA motif, was protected from DNase I by K562 nuclear extract. However, the other computer predicted motifs, NF-E2 and distal GATA, were disrupted in the mouse sequence, despite weak protection at the distal GATA motif in the DNase I footprint study. The unknown motif protected by K562 nuclear proteins was moderately conservative in the mouse (boxed in Fig. 5B ). The in vitro hypersensitive stretch of the positive strand for DNase I was also conservative (overlined with dashed line).
Site-directed Mutagenesis-To determine whether the DNase I, in silico, or phylogenetic footprint sites are functional in transactivation, NF-E2, Ets, and upstream or downstream GATA binding motifs were disrupted by site-directed mutagenesis. Fig. 6 shows that the constructs with mutated NF-E2, distal GATA, or Ets motif did not significantly decrease the promoter activity (p Ͼ 0.05). When the proximal inverse GATA motif was disrupted, promoter activity was remarkably suppressed to 8.6% of the wild type. Double mutation at both GATA motifs further suppressed the promoter activity to 5.8%. This indicated that the proximal GATA is critical for enhancer activity in the major HS. When the DNA fragment containing Fp-2 and -3 was removed from the wild type construct, promoter activity was decreased to 35.2% of the wild type, whereas the downstream sequence from the proximal GATA motif had no significant effect on the activity. These results suggest that the conservative DNA fragment intervening between the two GATA motifs is not critical but is somewhat involved in the enhancing activity, whereas the in vitro DNase I-hypersensitive stretch is not critical to the enhancing activity accessed by transient assay.
EMSA-To identify the binding factors for the predicted motifs, we performed EMSA (Fig. 7) . Probe1, which encodes an NF-E2-like motif, revealed a weak shift band, but this was competed out not only by excessive wild type probe 1 but also mutant probe 1 and wild type probe 2. The NF-E2-like motif appeared to be not involved in NF-E2 binding. Probe 2, which encodes a GATA motif, showed three bands, one of which super-shifted by anti-GATA-1 monoclonal antibody. The mobility of the shift band was identical with that of probe 6. The band was competed out by wild probe 2 and 6 but not by mutant probe 2 and 6. Probe 3 for unknown footprint 2 weakly bound to a nuclear protein. The shift band was competed out with the FIG. 4. In vitro DNase I footprint analysis of the human RHAG enhancer. Double-stranded DNA probes from Ϫ9756 (BlpI site) to Ϫ9315 (AccI site) was 5Ј end labeled by PCR as described under "Materials and Methods." The DNA probes labeled at directional (A) and antidirectional (B) strands were incubated with K562 (K) and HeLa (H) cells nuclear extracts or without proteins (N). The footprints by K562 nuclear extracts are indicated by vertical bars with numbers. The white boxes indicate in vitro DNase I-hypersensitive stretches. The predicted motifs for transcription factors are shown with arrows on both sides. unlabeled competitor. Probe 4 did not reveal any convincing bands, although it encoded a STAT-X-like motif. Probe 5 for footprint 3 revealed a shift band that was diminished by unlabeled self-competitor but not with unlabeled probe 6. Probe 6, which encoded the proximal GATA motif, revealed three shift bands. The slowest band super-shifted with anti-GATA-1 monoclonal antibody, which was competed out with unlabeled self-competitor, but not with unlabeled probe 2, mutant probe 2 and 6. These results suggest that the proximal GATA motif binds GATA-1 and has higher affinity than that in the distal position. 
DISCUSSION
Transcripts of the RHAG gene were observed by Northern blot analysis in erythroid lineage cells, K562, HEL, KU812E, and JK-1, but not in nonerythroid cell lines, HL60, Raji, HeLa, and HEK293 (18, 19) . Our previous promoter assay showed an inverse GATA motif at Ϫ53 bp as a critical element for the core promoter function in K562 and HEL but not in HeLa cells. However, a longer flanking sequence of 1868 bp diminished the activity in K562 and HEL cells (18) . Furthermore, we found an Rh null case of regulator type without mutation in the coding, promoter, and splicing sequences of RHAG gene. We therefore examined the erythroid-specific enhancing elements in this locus. In the present study, we identified and cloned an erythroid-specific HS with powerful, position-and orientation-independent enhancing activity in K562.
Hypersensitive sites have been identified in many genes (26 -28) . In erythroid-specific gene, the LCR of the ␤-globin (22), enhancer and promoter of the GATA-1 (29) , and the erythropoietin-receptor (30) genes are hypersensitive to DNase I in erythroid cells and are involved in erythroid-specific transactivation of these genes. The minimal enhancer of the RHAG gene encoded two GATA motifs. Site-directed mutagenesis studies have revealed that the proximal inverse motif alone is critical for enhancing activity. In the LCR of ␤-globin, not only GATA-1 but also the NF-E2 motif is important for both remodeling the chromatin structure of HSs and enhancer activity (31) (32) (33) . However, in the RHAG enhancer, the mutagenesis of other predicted motifs, NF-E2, distal GATA, STAT-X, and Ets sites, influenced on transactivation activity little or not at all. The NF-E2 and STAT-X motif did not show convincing factor binding in EMSA study. The binding affinity of distal GATA motif appeared lower than that of proximal motif, and footprinting was also less evident. Furthermore, NF-E2 and distal GATA motifs are not conservative in the mouse. These results suggest that the proximal GATA motif is solely critically involved in both remodeling the chromatin structure and in enhancer activity for the RHAG gene. Boyes et al. (34) have found that GATA-1 directly perturbs the interaction of DNA and histone octamer in vitro, resulting in DNase I hypersensitivity. Our in vivo data support their hypothesis.
The surface expression of RhAG on erythroblasts is initiated during early erythropoiesis and increase along with the maturation of erythroblasts (35, 36) . In our preliminary study, the amount of the RHAG transcript in K562 increased after inducing maturation with hemin (not shown). The surface expression of RhAG in the time course of erythroid differentiation appears to be under the control of transcription efficiency. The key transcription factor for RHAG promoter and enhancer, GATA-1, also increases along with erythroid differentiation (37, 38) . These facts indicate that the increased RhAG expression during erythropoiesis is mediated by the GATA-1 transcription level.
DNase I footprint analysis showed a broad protected area around the proximal GATA motif compared with the distal one. A transcription factor, which cannot be Ets, appears to cooperatively bind at this area with GATA-1. Co-activators of GATA-1 have been identified: friend of GATA (FOG) (39, 40) and p300/CBP (41). These co-activators synergistically activate transcription of the erythroid-specific regulatory region (39) and p300/CBP can act as histone acetyltransferase and also modify certain transcription factors (42) . The activity of GATA-1 is also under regulation by acetylation of p300/CBP (43) . Whether FOG or p300/CBP influence the binding of GATA-1 at the proximal motif and whether or not the flanking sequence of proximal GATA influences the formation of enhancer complex should be studied.
Downstream of the proximal GATA, in vitro DNase I-hypersensitive strands were observed, especially in the positive strand. Cleavability was shown even without nuclear proteins and was enhanced in a dose-dependent manner by adding nuclear proteins (not shown) but was not apparently erythroidspecific. Stamatoyannopoulos et al. (31) showed in vitro DNase I hypersensitivity in globin HS4, which was dependent on erythroid-specific transcription motifs for NF-E2 and GATA-1. We believe that the easily cleavable region of the RHAG enhancer has an accessible structure for DNase I and that it is enhanced by ubiquitous nuclear factors. Whether or not the cleavable DNA structure is physiologically involved in expression of the RHAG gene should be determined by in vivo experiments.
Although the actual function of RhAG in erythroid cells remains unknown, a homologue of human RHAG gene has been isolated not only from vertebrates such as the mouse (19) and zebrafish (AW419957) but also from nonvertebrates such as the fly (AF172639), nematode (44) , and marine sponge (17) . Furthermore, the ammonium transporter in nematode, yeast, plants, and bacterial organisms is homologous to RhAG (45) . These facts indicate that the product of the ancestral RHAG gene is a kind of transmembrane transporter, which was never an erythroid-specific protein. Inconsistent with Northern blot results, our preliminary reverse transcription-PCR and 5Ј rapid amplification of cDNA ends study showed transcripts FIG. 7 . EMSA study for the core enhancer sequence of human RHAG gene. Six double-stranded oligonucleotide probes were prepared as illustrated below to cover the predicted motifs and the in vitro footprint sits. The labeled probes were incubated with nuclear extracts of K562 cells. The competition study was carried out with cold competitors indicated above. The numbers with M indicate the mutant competitors. The supershift study was done with anti-GATA-1 monoclonal antibody. The arrowheads and arrows indicate the shift bands and supershift bands by GATA-1.
with identical transcription start sites of erythroid cells not only from nonhematopoietic organs but also from cells of nonerythroid lineage such as HeLa, HEK293, HL60, and Raji, although the transcript amounts in nonerythroid cells were much less than that in cells of erythroid lineage. These results suggest that RHAG is expressed in vertebrate erythroid cells dominantly but not specifically.
It has been well established that LCR of ␤-globin is highly conserved in mammals (46, 47) . The most conserved region of HSs is consistent with the functional sequence for transactivation (48 -50) . The RHAG enhancer was also highly conserved between human and mouse, especially the sequence around the proximal GATA motif, indicating that this motif is important for the erythroid dominant expression of this gene. The first linearly plotted stretch between human and mouse, which includes the enhancer sequence, was flanked in both species by SINE and LINE/L1 at the 5Ј and 3Ј ends, respectively. Their directions were also identical. In human, four Alu and three LINE/L1 repeats were inserted further downstream. The mouse gene contains a LINE/L1 and a MaLR insertion. These facts indicate that the 5Ј-flanking region of the RHAG gene is the preferable target sequence for retroviral transposition and that the enhancer was inserted in the upstream of RHAG ancestral gene in the same manner, resulting in the acquisition of erythroid dominant expression by this gene.
